Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen
Unpartnered assets: on the shelf or hidden treasure?
EP Vantage
Thu, 06/15/23 - 09:54 am
R&D
ALX Oncology
Argenx
Ascendis Pharma
Cytokinetics
Karuna Therapeutics
Madrigal Pharmaceuticals
Protagonist Therapeutics
Prothena
Ultragenyx Pharmaceutical
Unique Pharma
Ventyx Biosciences
Coya deems dementia drug R&D plan 'premature,' switches focus
Fierce Biotech
Mon, 06/12/23 - 10:00 am
Coya Therapeutics
R&D
frontotemporal dementia
dementia
tregs
Epistemic AI launches biomedical GPT at BIO
Pharmaphorum
Fri, 06/9/23 - 10:18 am
artificial intelligence
BIO 2023
R&D
Epistemic AI
Pricing law jeopardizes post-approval R&D process for cancer pills: analysis
Medical Marketing and Media
Mon, 06/5/23 - 10:04 pm
Inflation Reduction Act
R&D
drug pricing
oncology
China overtakes US in contributions to nature and science journals
The Guardian, UK
Tue, 05/30/23 - 10:02 am
China
R&D
academic research
Serial biotech founder Tim Springer on investing in startups and democratizing antibody research
BioPharma Dive
Fri, 05/26/23 - 09:47 am
Tim Springer
Harvard
biotech
R&D
10 Trends and Statistics for Clinical Trials in 2023
Xtalks
Sun, 05/21/23 - 07:43 pm
clinical trials
R&D
CROs
UCB partners with Ariceum for treatment of immune-related diseases and cancer
Biopharma Reporter
Fri, 05/12/23 - 11:30 am
UCB Pharma
Ariceum
R&D
radiopharmaceuticals
solid tumors
Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup
Fierce Biotech
Thu, 05/11/23 - 11:02 am
Takeda
R&D
gene therapy
earnings
Crohn’s disease
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model
BioSpace
Mon, 05/8/23 - 10:48 am
Bristol Myers Squibb
layoffs
R&D
New Jersey
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Biogen
Novartis
Sanofi
earnings
R&D
Roche opens new institute to advance research in human model systems
Pharmaceutical Technology
Thu, 05/4/23 - 09:26 am
Roche
R&D
organoids
Switzerland
Industry Seeks to Stimulate Innovation Through Grant Programs
BioSpace
Wed, 05/3/23 - 11:38 am
grants
R&D
Thermo Fisher Scientific
Merck KGaA
Qiagen
Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
BioSpace
Thu, 04/27/23 - 11:51 am
Biogen
Qalsody
tofersen
ALS
drug development
R&D
Boehringer Ingelheim opens new biotechnology R&D center in Germany
Pharmaceutical Business Review
Tue, 04/25/23 - 10:42 am
Boehringer Ingelheim
Germany
R&D
Mount Sinai launches regenerative medicine outpost to translate research into medicines
Fierce Biotech
Mon, 04/24/23 - 11:08 pm
Mount Sinai
regenerative medicine
R&D
Big Pharma’s R&D spending flatlined in 2022: What it means for the industry
Medical Marketing and Media
Mon, 04/24/23 - 11:45 am
R&D
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
R&D
Amgen
Bayer
Biogen
Gilead Sciences
Merck KGaA
Moderna Therapeutics
Novo Nordisk
Regeneron Pharmaceuticals
UCB
Vertex Pharmaceuticals
Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D
Fierce Biotech
Fri, 04/21/23 - 10:14 am
Boehringer Ingelheim
RetinAI
artificial intelligence
geographic atrophy
R&D
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »